NCT05369104View on ClinicalTrials.gov

Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.

PHASE2UnknownINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

December 16, 2023

Study Completion Date

June 16, 2025

Conditions
Infection of Total Hip Joint ProsthesisInfection of Total Knee Joint Prosthesis
Interventions
BIOLOGICAL

Anti-Staphylococcus aureus Bacteriophages

Single intra-articular injection

Trial Locations (1)

69004

RECRUITING

Pr Tristan Ferry, Lyon

Sponsors
All Listed Sponsors
lead

Phaxiam Therapeutics

INDUSTRY

NCT05369104 - Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. | Biotech Hunter | Biotech Hunter